Skip to main content

Dyadic International Inc

DYAI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001213809

In the last 90 days, Dyadic International Inc insiders filed 0 open-market purchases and 2 sales; 39 institutions reported holding it in 13F filings for Q2 2026, worth $4.14M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Dyadic International Inc changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of DYAI: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders3541+6
Shares4.78M5.12M+337.5K (+7.1%)
Value$4.98M$8.33M+$3.35M (+67.4%)

New holders (9)

Institutions that held Dyadic International Inc at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to DYAI in Q4 2024
InstitutionSharesValue% of portfolio
Truist Financial Corp250,000$427.5K0.00%
Inlet Private Wealth, LLC30,000$52.5K0.01%
Jane Street Group, LLC25,711$45.0K0.00%
Millennium Management LLC16,193$28.3K0.00%
Wolverine Trading, LLC14,263$25.4K0.00%
Two Sigma Securities, LLC14,037$24.6K0.00%
Simplex Trading, LLC4,407$7.00K0.00%
UBS Group AG274$4800.00%
SBI Securities Co., Ltd.70$1230.00%

Sold out (3)

Institutions that held Dyadic International Inc at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of DYAI in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
XTX Topco Ltd13,252$13.8K
Citadel Advisors LLC7,911$8.23K
Advisor Group Holdings, Inc.1,000$1.04K